Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
February 29, 2024 5:50 AM ESTTruist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024... More
JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call
February 27, 2024 12:09 PM ESTJPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)
The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More
